The size of the MEA High-Resolution Melting Analysis Market was valued at USD 39.72 million in 2022. It is further projected to be growing at a CAGR of 2.07% and worth USD 44.00 billion by 2027.
Non-Invasive Prenatal Testing is used to identify mutations, genetic abnormalities, and polymorphisms. High-Resolution Melting Analysis is a branch of molecular biology which includes other techniques like genotyping.
During the procedure of High-Resolution Melting, the amplified region, termed an amplicon, is precisely heated at about 50 ËšC to 95 ËšC. Amid this temperature, the amplicon touches its melting point, and the two strands of DNA are parted or melt apart from each other. The splitting of these strands is noted and compared with that of a normal person. Abnormalities are identified in these DNA strands by this comparison, which yields mutations and other differences.
The growth of the Middle East and Africa High-Resolution Melting Analysis Market is mainly driven by the rising frequency of infectious diseases and genetic ailments, improving healthcare infrastructure, rising public-private investments in the genomics sector, and the upsurge in the count of the elderly populace. The benefits offered by HRM over genotyping are also among the chief drivers of the market. Low awareness, technological discrepancies, and the low penetration of High-Resolution Melting Analysis technology are among the market growth constraints.
This research report on MEA High-Resolution Melting Analysis Market has been segmented and sub-segmented into the following categories.
By Product and Service:
By End User:
Companies in the Middle East & Africa High-Resolution Melting Analysis market are Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands). Other players in the market include Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.), among others.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com